Study of Cemiplimab - TP Induction Chemotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Clinical trial NCT05376553 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05376553
- Sponsor
- Krzysztof Misiukiewicz
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-20
- Primary completion
- 2025-10-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.